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Neonatal Subventricular Zone Neural Stem Cells
Release Extracellular Vesicles that Act
as a Microglial Morphogen
Mary C. Morton,1 Victoria N. Neckles,1 Caitlin M. Seluzicki,1 Jennie C. Holmberg,1 and David M. Feliciano1,2,*





Subventricular zone (SVZ) neural stem cells (NSCs)
are the cornerstone of the perinatal neurogenic
niche. Microglia are immune cells of the nervous sys-
tem that are enriched in the neonatal SVZ. Although
microglia regulate NSCs, the extent to which this
interaction is bi-directional is unclear. Extracellular
vesicles (EVs) are cell-derived particles that encase
miRNA and proteins. Here, we demonstrate that
SVZ NSCs generate and release EVs. Neonatal
electroporated fluorescent EV fusion proteins were
released by NSCs and subsequently cleared from
the SVZ. EVs were preferentially targeted to micro-
glia. Small RNA sequencing identified miRNAs within
the EVs that regulate microglia physiology and
morphology. EVs induced a transition to a CD11b/
Iba1 non-stellate microglial morphology. The transi-
tion accompanied a microglial transcriptional state
characterized by Let-7-regulated cytokine release
and a negative feedback loop that controlled NSC
proliferation. These findings implicate an NSC-EV-
microglia axis and provide insight to normal and
pathophysiological brain development.
INTRODUCTION
Neurons are produced by stem cells that reside in discrete re-
gions of the adult mammalian brain called neurogenic zones.
The subventricular zone (SVZ) is one of two canonical neuro-
genic regions that produce neurons in the adult mammalian brain
(Lim and Alvarez-Buylla, 2016). The renewal capacity endowed
by the SVZ likely allows for continued adaptation to environ-
mental olfactory cues by generating olfactory bulb neurons
(Lledo and Valley, 2016). Mutations in SVZ neural stem cells
(NSCs) make them a likely culprit in the generation of certain tu-
mors and malformations (Dietrich et al., 2008; Vescovi et al.,
2006; Zhou et al., 2011). Intercellular communication within the
SVZ is paramount for producing the appropriate numbers and
types of cells (Choe et al., 2015). Therefore, the identification
of mechanisms by which niche homeostasis is maintained or
perturbed has far-reaching implications.
Microglia are hematopoietically derived myeloid cells derived
from yolk sac macrophages that function as neuro-resident im-
mune cells (Ginhoux et al., 2010; Prinz et al., 2017). Myeloid cells
invade the mid-gestation brain through the vasculature and sub-
sequently produce 95% of microglia during the first postnatal
weeks (Alliot et al., 1991, 1999). A band of microglia is found
within the SVZ during this perinatal period (Shigemoto-Mogami
et al., 2014). During adulthood, this band of microglia disperses
to form an evenly distributed immunological matrix within the pa-
renchyma (Shigemoto-Mogami et al., 2014). Few studies have
demonstrated that SVZ NSCs influence microglia (Pluchino
and Cossetti, 2013; Sato, 2015).
Extracellular vesicles (EVs) are found throughout the developing
nervous system (Morton and Feliciano, 2016). EVs are membra-
nous particles that range in size from 50–350 nm and encapsulate
microRNA (miRNA),mRNA, andproteins (RaposoandStoorvogel,
2013). EVs are classified into two categories: exosomes and ecto-
somes. Exosomes are intraluminal vesicles that have been exocy-
tosed followingmultivesicular body fusion with the cell membrane
(Cocucci and Meldolesi, 2015). Ectosomes are larger than exo-
somes and are generated by outward budding of the cell mem-
brane (Cocucci andMeldolesi, 2015). Recent studies demonstrate
thatSVZ-derivedneural stem/precursorcells releaseEVs (Cossetti
et al., 2014; Iraci et al., 2017). Neurosphere-derived EVs carry
miRNA,mRNA, and proteins such as the interferon gamma recep-
tor andactiveasparaginase (Cossetti et al., 2014; Iraci et al., 2017).
Adult hypothalamic neuronal stem cells also produce exosomes
thathave longevity-extendingproperties (Zhangetal., 2017).How-
ever, the in vivo cellular targets of NSC EVs are unclear.
This study was performed to determine the extent to which
SVZ NSCs release EVs and to identify in vivo NSC EV targets,
if any. Neonatal SVZ NSCs were found to release EVs. Neonatal
intraventricular transplanted NSC EVs were selectively taken up
by microglia. NSC EV uptake was associated with a CD11b/
Iba1-positive morphological shift to a reduced complexity.
RNA sequencing and cytokine analysis revealed a change in
the transcriptional network and cytokine profile of microglia
following NSC exosome treatment.
RESULTS
Neonatal SVZ NSCs Release EVs
Primary SVZNSCswere cultured as amonolayer frompost-natal
day 0 (P0) mice and subjected to immunocytochemistry for the
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NSCmarker protein Nestin. Neonatal SVZ cultures were double-
cortin (DCX)-negative (data not shown), whereasmost cells were
Nestin-positive (92%) (Figure 1A). Neonatal SVZ NSC condi-
tioned medium was subjected to low-speed centrifugation to re-
move debris and dead cells, followed by nanoparticle tracking
analysis. Four peaks were identified at 89, 129, 199, and
263 nm with an average size of 164.9 ± 7.2 nm. In addition to
conditionedmedium, we analyzedmedium subjected to an ultra-
centrifugation EV enrichment protocol. This NSC P100 fraction
contained four peaks at 109, 154, 209, and 312 nm with an
average size of 190.7 ± 5.2 nm (Figure 1B). EVs were also ex-
tracted using polymer precipitation and had an average size of
167.0 ± 3.8 nm (data not shown). NSC EV size was confirmed
by electron microscopy and confirmed to have an exosome
morphology (Figure 1C). CD63, an EV marker protein, was
confirmed to be expressed in NSCs and EVs (Figure 1D). Another
EV protein, CD9, was detected in dorsal forebrain extracts. CD9
was present in the neonatal brain and upregulated by P7 (Fig-
ure 1E). CD9 was detected in primary neonatal SVZ NSC EVs
by western blot (Figure 1F). Moreover, ALIX, an exosome cargo
protein, was present in SVZ NSC EVs (Figure 1G). CD9 expres-
sion was further confirmed in primary SVZ NSC cultures by
immunocytochemistry (Figures 1H and 1I). CD9 was present
within the processes of SVZ NSCs and was peri-nuclear, consis-
tent with a previous report (Llorens-Bobadilla et al., 2015). To
examine CD9 protein expression in vivo, immunohistochemistry
was performed on P0 and P4 brains. CD9 expression was pre-
sent along the ventricular wall in Nestin-positive NSCs at P4 (Fig-
ures 1J–1L). The enrichment of CD9 within the neonatal SVZ was
consistent with in situ hybridizations of sagittal sections from the
Figure 1. Neonatal SVZ NSCs Release EVs
(A) Immunocytochemistry for Nestin (green) and TO-PRO-3 (blue) in primary monolayer culture of P0 SVZ NSCs after 2 days in vitro. Scale bar, 25 mm.
(B) Nanosight particle profile of EVs derived from the P100 fraction of NSCs.
(C) Electron micrograph of an NSC-derived exosome. Scale bar, 100 nm.
(D) Western blot of CD63 in NSC lysate or NSC EV P100 fractions.
(E) Western blot of CD9 and b3-tubulin from dorsal forebrain extracts.
(F) Western blot for ALIX in SVZ NSC EV P100 fractions as in (D).
(G) Western blot for CD9 from NSC EV P100 fractions as in (D).
(H and I) Immunohistochemistry of Nestin (green), TO-PRO-3 (blue), CD9 (red) (H), and CD9 (I) in P0 SVZ NSC cultures. Scale bars, 12.5 mm.
(J) Nestin (green) and CD9 (red) expression within the SVZ at P0. Scale bar, 5 mm.
(K and L) Nestin (green), CD9 (red), and TO-PRO-3 (blue) within the SVZ at P4. Scale bars, 25 mm.
(M) In situ hybridization of CD9 in a P14 sagittal brain section from the Allen Brain Institute Developing Mouse Brain Atlas. Image credit: Allen Institute.
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Figure 2. SVZ NSCs Release CD9 In Vivo
(A) Schematic diagram of a coronal section, indicating the direction of electrodes used for neonatal electroporation; black rectangles indicate the corresponding
regions imaged. Image credit: Allen Institute.
(B) 53 image of the SVZ of a P2 mouse following P0 electroporation with Tomato (red) and CD9-GFP (green). Scale bar, 100 mm.
(C) 203 image of the dorsolateral SVZ from (B). Scale bar, 50 mm.
(D) 203 image of the ventro-lateral SVZ from (B). Scale bar, 50 mm.
(E–H) 633 images of SVZ NSCs electroporated with Tomato (red) and CD9-GFP (green) demonstrating differences in CD9-GFP localization in apical and basal
processes (E) and soma (F). Note the distribution of Tomato and CD9-GFP (G, merge) and CD9-GFP alone (H). Scale bars, 50 mm.
(I) CD9-GFP distribution in relation to the Tomato-positive SVZ NSC soma located at the ventricle. Arrows point to CD9-GFP in the basal fiber, and arrowheads
point to apical fibers with CD9-GFP present. Scale bar, 50 mm.
(legend continued on next page)
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Allen Brain Institute (Figure 1M; Henry and Hohmann, 2012).
These results confirm that neonatal SVZ NSCs release EVs
in vitro.
SVZ NSCs Release CD9 In Vivo
N2a cells were transfected with CD9-GFP- and Tomato (fluores-
cent protein)-encoding DNA (Figure S1A). CD9-GFP exhibited a
cytoplasmic distribution in N2a cells and could be detected in
extracellular vesicle and exosome fractions from sucrose gradi-
ents along with ALIX, CD63, and a His tag present within CD9-
GFP (Figure S1B). Approximately 47% (n = 9, 46.59 ± 4.943)
of CD9-GFP particles were extracellular, consistent with the
hypothesized release of CD9 (Figure S1C). N2a CD9-GFP exo-
somes incubated with naive N2a cultures were detected sur-
rounding, but not within, N2a nuclei (Figure S1D). CD9-GFP
uptake in N2a cells was confirmed in cells transfected with
Tomato plasmids (Figure S1E). Time-lapse imaging demon-
strated considerable movement of intracellular CD9-GFP (Fig-
ure S1F). The release of CD9-GFPwas confirmed by live imaging
(Figure S1G).
To study NSC exosomes, Tomato fluorescent protein- and
CD9-GFP-encoding plasmids were electroporated into the
SVZ of P0 mice, and NSCs were examined (Figure 2A). Expres-
sion of Tomato fluorescent protein was detected throughout the
soma (Figures 2B–2D). CD9-GFP-positive cells were most
frequent along the ventro-lateral ventricular wall (Figures 2B–
2D). CD9-GFP was detected within cells with a B1-like NSC
morphology (Figures 2E–2H). CD9-GFP localized to the apical
and basal processes (Figures 2E and 2I). Cells with an NSC
morphology stained positively for glial fibrillary acid protein
(GFAP) by P7 (Figures 2J and 2K). B1-like tomato/CD9-GFP-
positive cells were also Nestin-positive, confirming their identity
as NSCs (Figures 2L and 2M). CD9-GFPwas detected outside of
electroporated cells (Figures 2N and 2O).
We detected 52 Tomato-positive cells/SVZ 48 hr post-elec-
troporation (Figure 2P). Tomato-positive cells remaining in the
SVZ significantly decreased by 80% from P2–P7 (Figure 2P).
This result is consistent with the prevailing notion that NSCs
generate transit-amplifying cells that produce neuroblasts and
migrate away from the SVZ to the olfactory bulb (OB). Similar
to transient thymidine labeling (for example, bromodeoxyuridine
[BrdU]), DNA plasmids are diluted from dividing NSCs. NSCs
were co-electroporated with either of two CD9-GFP plasmids
that had cytomegalovirus (CMV) or CAG promoters. CD9-GFP
expression was limited to 7.52% (CMV) and 24% (CAG) of
Tomato-positive cells in the SVZ. CAG-CD9-GFP was co-ex-
pressed more frequently than CMV-CD9-GFP in Tomato-posi-
tive cells, which was not surprising given that CAG-CD9-GFP
was generated by cloning it into the Tomato plasmid. CAG-
CD9-GFP was therefore used for quantification. The percentage
of cells co-expressing CD9-GFP and Tomato significantly
decreased from 24% to 7.32% at P7 (Figure 2Q). The reduction
in the percentage of CD9-GFP/Tomato co-expressing cells was
similar in P21–P28 brains.
When considering the reduction of Tomato-positive cells, and
consistent with Tomato/CD9-GFP double-positive cells, these
results support a model for which 71% of CD9-GFP/Tomato-
positive cells are NSCs. This is likely an underestimate because
NSCs also generate ependyma and quiescent NSCs that remain
in the SVZ. For every electroporated cell 48 hr post-electropora-
tion, at least one extracellular particle could be detected (54.77
CD9-GFP particles/image) (Figure 2R). The number of CD9-
GFP particles outside of co-electroporated Tomato NSCs
decreased by 7 days post-electroporation to 18.20 particles
and remained similar (19.06) in P21–P28 mice (Figure 2R). These
results demonstrate that SVZ NSCs release CD9, which is sub-
sequently cleared from the extracellular milieu.
SVZ NSCs Selectively Target Microglia
It was tempting to speculate that the commensurate reduction of
extracellular CD9 was consistent with amodel in which NSC EVs
were targeted for removal. The fact that extracellular CD9-GFP-
positive particles were released and decreased over time could
reflect a passive or active clearing process. An influx of microglia
into the neonatal SVZ occurs contemporaneously with the loss of
CD9-GFP. We therefore hypothesized that active clearing by
microglia might be responsible for the loss in total number
of CD9-GFP-positive particles. Microglia express the ionized
calcium-binding adaptor molecule 1 (Iba1). We found that
Iba1-positive microglia co-localized with extracellular CD9-
GFP from neonatal SVZ electroporations (Figures 3A and 3B).
As an initial experiment, to perform a more unbiased assess-
ment, N2a exosomes from CD9-GFP-transfected cells were
labeled with the fluorescent lipophilic dye DiI (1,1’-Dioctadecyl-
3,3,30,30-Tetramethylindocarbocyanine Perchlorate). Exosomes
were then injected intraventricularly into the lateral ventricles of
neonatal mice (Figure 3C). One to seven days after injection,
mice were harvested, and brains were isolated. A population of
cells near the lateral ventricles were labeled with DiI and GFP
(Figures 3D–3E). Cells occasionally had a stellate morphology
reminiscent of microglia (Figure 3F). Staining with Iba1 confirmed
the identity of these cells as microglia (Figure 3F). Approximately
(J) SVZ from a Tomato-electroporated (red) and CD9-GFP-electroporated (green) mouse stained for GFAP (blue). Scale bar, 25 mm.
(K) Individual Z section from (J). Scale bar, 25 mm.
(L) 203 image of a CD9-GFP-electroporated (green) and Tomato-electroporated (red) brain stained for Nestin (white). Scale bar, 25 mm.
(M) Individual Z section from (L). Scale bar, 25 mm.
(N) 633 zoom-2 image within the SVZ of Tomato-electroporated (red) and CD9-GFP-electroporated (green) mice showing extracellular CD9-GFP-positive
particles. Scale bar, 5 mm.
(O) A tracing of an individual slice showing a Tomato-positive cell body (red) and CD9-GFP (green).
(P) Quantification of the number of Tomato-positive SVZ cells from P2–P28.
(Q) Quantification of CD9-GFP and Tomato-positive cells in the SVZ from P2–P28.
(R) Quantification of the number of extracellular CD9-GFP-positive particles in the SVZ from P2–P28.
See also Figure S1. Data are represented as mean ± SEM. **p < 0.01, ***p < 0.001, ****p < 0.0001.
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93% (92.84 ± 32.44, n = 8) of DiI exosomes co-localized with
microglia at P2 and 80%at P7 (79.77 ± 5.448, n = 14) (Figure 3G).
Because N2a cells are derived from a mouse tumor, we
wondered to what extent these results reflected and were
consistent with NSC-derived EVs. Therefore, NSCs from P0
mouse brains were cultured. SVZ NSC EVs from P100 fractions
were labeled with DiI and injected into P0 mice. NSC EVs were
predominantly targeted to Iba1-positive microglia (Figure 3H).
EV-labeled microglia often had a rounded appearance and
were frequently contiguous with the lateral ventricles and SVZ.
CD68 and CD11b are two markers of microglia that are ex-
pressed in neonatal SVZ microglia. Consistent with these find-
ings, DiI-labeled cells were double-positive for CD68 and Iba1
as well as CD11b and Iba1 (Figures 3I–3K). The majority of
NSC EV P100-labeled cells were Iba1-positive microglia (control
24 hr = 76.52 ± 4.608, UV-treated 24 hr = 69.64 ± 9.661, control
Figure 3. NSC EVs Selectively Target
Microglia
(A) 203 image showing Iba1-positive microglia
(blue) in proximity to Tomato-electroporated (red)
cells and CD9-GFP-positive particles (green).
Scale bar, 50 mm.
(B) 203 image of (A).
(C) Schematic of EV transplantations.
(D and E) DiI (D) and CD9-GFP (E, green) fluores-
cence within the SVZ of P7 brains following CD9-
GFP N2a EV transplantation. Scale bar, 50 mm.
(F) Brain transplanted with DiI-labeled EVs (red)
and stained for the microglia marker Iba1 (white).
Scale bar, 50 mm.
(G) Quantification of co-localization of Iba1 and DiI
following N2a transplantations and analysis at P2
and P7.
(H) 203 image of a lateral SVZ following primary
NSC DiI-labeled EV (red) transplantation stained
for Iba1 (green). Scale bar, 50 mm.
(I) 203 image of a dorso-lateral SVZ following
primary NSC DiI-labeled EV (red) transplantation
stained for CD68 (green). Scale bar, 50 mm.
(J and K) 203 (J) and 633 (K) image of SVZ
following primary NSC DiI-labeled EV (red) trans-
plantation stained for CD11b (green) and Iba1
(white). Scale bars, 25 mm.
(L) Quantification of Iba1 co-localized EVs without
(green) or with (red) UV treatment from NSC EV
transplantations.
(M) Quantification of the number of Iba1-positive,
DiI-positive cells in the SVZ from P1–P7 from NSC
exosome transplantations.
Data are represented as mean ± SEM.
48 hr = 77.57 ± 6.263, UV-treated 48 hr =
61 ± 8.860) (Figure 3L). Because internal
nucleic acid content is proposed to be
transferred to and modify recipient cells,
EVs were subjected to UV treatment,
but no significant change in Iba1 co-
localization was documented (Figure 3L).
Exosomes were further isolated from SVZ
NSC EVs and transplanted into neonates.
Iba1-positive microglia accounted for more than half of all exo-
some-labeled cells (P1 = 57.07 ± 8.134, P2 = 51.46 ± 7.996,
P7 = 51.28 ± 12.13) (Figure 3M). The percentage of incorporation
is not simply because microglia represent 50% of the total num-
ber of cells in the SVZ. Although the quantity of microglia fluctu-
ates over time, microglia account for 4%–10%of total cells in the
SVZ (Shigemoto-Mogami et al., 2014). This number is substan-
tially less than the exosome uptake bymicroglia. Taken together,
SVZ NSC exosomes selectively label microglia.
SVZ NSC EVs Act as a Microglial Morphogen
The appearance of microglia in the SVZ coincided with the
release and uptake of NSC EVs. To identify the functional
effects of EVs on microglia, small RNA sequencing was
performed. RNA sequencing identified numerous miRNAs in
NSC P100 EVs, and we considered the most abundant
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miRNAs having reads 10-fold greater than the average miRNA
(Figure 4A). miR-9, Let-7, miR-26, and miR-181 were highly
enriched in NSC EVs. Members from each of these families
have roles in regulating microglia morphology and physiology
(Kumar et al., 2015; Lehmann et al., 2012; Yao et al., 2014;
Zhang et al., 2015). Based on these results, it was hypothe-
sized that EVs regulate CD11b-positive microglia to induce a
rounded non-stellate phenotype (Figure 4B). We noted that,
in comparison with the contralateral hemisphere, NSC P100
EV transplantation increased CD11b-positive microglia (Fig-
ures 4C and 4D). UV pre-treatment of EVs resulted in fewer
CD11b-positive microglia in comparison with control SVZ
NSC EVs (Figure 4E). 24 hr post-transplantation, labeled
microglia were found grasping the ventricle, contiguous with
and on the apical portion of the lateral ventricular wall or
in clusters within the choroid plexus. Microglia within the
ventricle or choroid were often CD11b-positive and rounded,
having an average ellipticity of 0.64; in comparison, unlabeled
CD11b-positive microglia were more stellate, with a lower
ellipticity of 0.36 (Figure 4F). Because EVs induced CD11b mi-
croglia and because CD11b was more frequently associated
with a rounded morphology, microglia morphology was
analyzed following NSC EV treatment. Microglia generate filo-
podium-like processes that survey the extracellular environ-
ment (Nimmerjahn et al., 2005). The number of processes
was quantified in Iba1-positive microglia. In comparison with
non-labeled cells within the same slice, NSC EV-labeled mi-
croglia were less complex and this phenotype persisted up
to 7 days (Figure 4G). SVZ NSC exosome-labeled microglia
also had a reduced complexity that was reversed by UV pre-
treatment (Figure 4H). Based on these experiments, the con-
tent of NSC exosomes appeared to be important for the
morphological changes of microglia. Because several mem-
bers of the Let-7 family were the most abundant and frequently
identified EV miRNAs, we hypothesized that exosomal Let-7
might regulate microglia morphology. Exosomes from N2a
cells transfected with a Let-7 sponge were collected. Exo-
somes were subjected to mock or synthetic Let-7 transfec-
tions and transplanted into the SVZ of neonatal mice. Syn-
thetic Let-7 miRNA-transfected exosomes induced microglia
to acquire a rounder appearance that differed from the
mock-transfected exosomes (Figures 4I–4L). These results
confirm that SVZ NSCs release exosomes that are targeted
to, taken up by, and modify microglia.
NSC EVs Activate a Microglia Transcriptional Network,
Resulting in an NSC Feedback Loop
Next-generation RNA sequencing was performed to gain mech-
anistic insight into how EVs modify microglia. Microglia treated
with NSC EVs had 1,713 transcripts that were upregulated
greater than 2-fold (Figure 5A). 1,175 were significantly downre-
gulated by greater than 2-fold (Figure 5A). Gene ontology anal-
ysis revealed that immune system processes and inflammatory
responses were themost highly enriched and significantly repre-
sented terms (Figure 5B). Examination of transcripts within heat-
maps indicated that the most highly upregulated transcripts
included cytokines such as interleukin-1a (IL-1a), IL-1b, and
IL-6 (Figure 5C). In agreement, network analysis of the top differ-
entially regulated transcripts included a cytokine node at the
core of this network (Figure 5D). Upregulation of cytokines
was unbiasedly validated in microglia-conditioned medium (Fig-
ure 5E). Exosome treatments were sufficient to upregulate cyto-
kines, and we found no evidence that the effect was due to cyto-
kines present within the EVs (data not shown). The regulation
of cytokines is likely dependent on NSC exosome content.
Because Let-7 members were the most prevalent miRNAs de-
tected and because Let-7 has been shown to activate the endo-
somal TLR-7 receptor, we hypothesized that Let-7 family mem-
bers may modulate the transcriptional response that induces
cytokines. To test this hypothesis, plasmids expressing Let-7
sponges were transfected into N2a cells, and then synthetic
Let-7 miRNAs were transfected into EVs. EVs were then added
to microglia, and cytokine responses were measured. Synthetic
Let-7-containing EVs stimulated robust release of cytokines
from microglia that mimicked the effect of NSC EVs (Figure 5F).
SVZ NSC EVs induced a minor response from RAW 264.7 mac-
rophages that differed from microglia (Figure S2). For example,
macrophages released IL-1a, IL-6, and granulocyte-colony stim-
ulating factor (G-CSF). In contrast, G-CSF was not increased for
microglia, whereas IL-1bwas not stimulated in macrophages af-
ter NSC EV treatment. We hypothesized that the release of fac-
tors from microglia following exosome uptake may exert a feed-
back response to SVZ NSCs. To test this hypothesis, and as a
test of the functional significance of NSC exosome uptake bymi-
croglia, conditioned medium from non-treated or EV-treated mi-
croglia was injected back into the lateral ventricles of P0 mice,
and EdU (5-ethynyl-2’-deoxyuridine) labeling was performed
(Figure 5G). Conditioned medium from microglia treated with
exosomes, but not control microglia, reduced the number of
dividing NSCs (Figure 5H). Taken together, these results demon-
strate a robust and significant effect of exosomes on microglia
signaling that forms a negative feedback loop to NSCs during
the neonatal period.
DISCUSSION
Here evidence is provided that EVs are released from neonatal
SVZ NSCs and subsequently taken up by microglia. Primary
SVZ NSCs released EVs, as determined by nanosight particle
tracking analysis and western blotting for EV marker proteins.
Of the EV proteins, CD9 was found to be co-localized in vivo
and in vitro with Nestin-positive NSCs. These results are consis-
tent with the well-documented expression of CD9 in stem and
stem-like cells (Karlsson et al., 2013; Kolle et al., 2009; Leung
et al., 2011; Llorens-Bobadilla et al., 2015; Oka et al., 2002; Shi
et al., 2017; Terada et al., 2002). A recent study demonstrated
CD9 expression within adult SVZ NSCs (Llorens-Bobadilla
et al., 2015). CD9 is also widely reported to be released with
EVs, including from N2a cells.
Cerebrospinal fluid (CSF) contains EVs that are present during
perinatal brain development (Feliciano et al., 2014; Tietje et al.,
2014). To determine whether NSCs may generate EVs, neonatal
electroporations of CD9-GFP were performed. Extracellular
CD9-GFP was found within 48 hr after electroporation. Previous
studies have also reported the release of particles during neuro-
genesis that correlate with different developmental processes,
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Figure 4. NSC EVs Act as a Microglial Morphogen
(A) Identity and quantity of NSC EV miRNAs.
(B) Schematic of predicted NSC EV miRNA functions.
(C and D) Image demonstrating CD11b-labeled (green) cells in DiI-labeled EV-transplanted (red) ipsilateral (C) or contralateral (D) hemispheres. Scale bar, 25 mm.
(E) Quantification of the percentage of CD11b- or CD68-positive microglia.
(F) Measurement of regional microglia ellipticity.
(G) Average number of cellular processes in Iba1-positive microglia following EV transplantation.
(H) Quantification of the number of cellular processes in Iba1-positive microglia labeled by control or UV pre-treated NSC exosomes.
(I) Quantification of the number of cellular processes following treatment with control N2a exosomes or N2a exosomes packaged with synthetic Let-7.
(J and K) Representative images of control (J) or Let-7 (K) EV transplantations from (I). Scale bars, 50 mm.
(L) Quantification of microglia ellipticity following control or Let-7 exosome uptake.
Data are represented as mean ± SEM. *p < 0.05, ***p < 0.001, ****p < 0.0001.
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Figure 5. NSC EVs Activate a Microglia Transcriptional Network, Resulting in an NSC Feedback Loop
(A) Volcano plot of p values and fold changes of microglia mRNAs after NSC EV treatment.
(B) Gene ontology terms represented by p value and number of genes changed in the microglia gene network.
(C) Bi-clustering heatmap of the top 30 significantly altered mRNAs from control or NSC EV-treated microglia.
(D) Gene network analysis of the top differentially expressed microglia mRNAs demonstrates clustering of cytokines and cytokine receptors.
(E) Cytokine levels in medium from control and NSC EV-treated microglia.
(F) Cytokine levels from microglia-conditioned medium from N2a control and synthetic Let-7 transfected exosomes. #, = fluorescence.
(G) Representative images of brains injected with control or NSC EVmicroglia-conditioned medium, Edu-labeled (green), subjected to immunohistochemistry for
Nestin (red), and counterstained with TO-PRO-3 (blue). Scale bar, 25 mm.
(H) Quantification of the percentage of EdU-positive, Nestin-positive neural stem cells.
See also Figure S2. Data are represented as mean ± SEM. **p < 0.01.
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such as neuroblast delamination from the ventricular surface
(Das and Storey, 2014). Therefore, SVZ NSC EVs represent
another member of the ever-increasing developmental EV
repertoire.
An age-dependent decrease in the number of extracellular
CD9-GFP-positive particles was identified that coincided with
the influx of microglia. Using an unbiased approach of labeling
EVs, we found that EVs target microglia, as indicated by the
markers Iba1, CD11b, and CD68. Iba1-positive cells accounted
for the majority of DiI-labeled cells. The mechanism involved in
the selectivity of uptake is unclear. Nevertheless, oligodendro-
cyte and glioma exosomes are reported to be taken up by mi-
croglia (Fitzner et al., 2011; van der Vos et al., 2016). Because
EV content is proposed to contain encoded information, next-
generation small RNA sequencing was performed and identi-
fied several miRNAs, including miR-9, Let-7, and miR-181
members. The presence of these regulatory miRNAs evoked
us to hypothesize that EVs may function as a non-canonical
morphogen. Consistent with this finding, EV uptake was asso-
ciated with a shift to a reduced number of cellular processes
and a rounded appearance as well as an accumulation within
the SVZ. We cannot rule out the possibility that non-nucleic
acid components contribute to the effect of EVs on microglia,
nor can a nutritive role for EVs be excluded. Nevertheless,
these findings establish relevance for NSC EVs on microglia
in the neonatal brain.
NSC EVs had a direct effect on microglia in primary culture.
The uptake of EVs resulted in a robust re-wiring of transcriptional
networks, most notably those associated with immune system
gene ontology terms, including immune system process, inflam-
matory response, defense response to virus, neutrophil chemo-
taxis, positive regulation of cytokine secretion, and I-kappa
B kinase/nuclear factor kB (NF-kB) signaling. Transcriptional
changes corresponded to enhanced cytokine release, most
notably IL-6 and tumor necrosis factor alpha (TNF-a). Although
the precise molecular mechanism by which EVs stimulate this
response is unclear, levels of Let-7 family members altered the
extent of cytokine release. It is possible that NSC EVs and
Let-7 function as pattern recognition signals. In this case, during
development, NSC EVs function as a morphogen-associated
molecular pattern to control microglia. To determine the physio-
logical effects of this signal, conditioned medium from microglia
was injected into the lateral ventricles of mice. Conditioned me-
dium from exosome-treated microglia regulated NSC prolifera-
tion. The effect of microglia-conditioned medium on NSCs is
consistent with microglia regulation of dentate gyrus and embry-
onic ventricular zone NSCs (Cunningham et al., 2013; Gebara
et al., 2013).
In conclusion, the results of this study demonstrate that SVZ
NSCs release EVs that are selectively targeted to and function-
ally affect microglia. These results compel us to propose a
conciliatory model of EV function that explains the discrepancy
between EVs carrying refuse and information. In the case of
neonatal development, NSC EVs function as a non-canonical
morphogen that affects the state, organization, and morphology
of microglia in the brain. It is therefore not surprising that EVs are




Experiments were performed according to guidelines set forth by the Clemson
University Institutional Animal Care and Use Committee and NIH Guide for the
Care and Use of Laboratory Animals. Pregnant CD-1 mice obtained from
Charles River Laboratories were housed under pathogen-free conditions
with a 12-hr light/dark cycle. For primary cell culture, EV and exosome prepa-
ration, and sequencing, pooled samples of both genders were used.
Electroporation
Electroporations were performed as described previously (Feliciano et al.,
2013). Briefly, DNA combined with fast green was injected into the lateral
ventricle. Pups were electroporated with a BTX ECM 830 Square Wave Pulse
generator and Tweezertrodes (Harvard Apparatus).
Slice Preparation and Immunohistochemistry
Slices were prepared as described previously (Feliciano et al., 2011).
Antibodies used included Nestin (Novus Biologicals, NB100-1604), CD9
(eBioscience, 14-0091-81), Iba1 (Novus, NB100-2833), CD68 (Bio-Rad,
MCA1957), CD11b (Bio-Rad, MCA711G), or GFAP (Cell Signaling Technology,
12389S). Secondary antibodies conjugated to Alexa Fluor 488 or Alexa Fluor
633 (Life Technologies) were incubated overnight at 4C.
Imaging
Images were taken on a Leica TCS SPE spectral confocal microscope using
203, 403, or 633 oil immersion lenses. Images were processed using Leica
Application Suite X software (Leica Microsystems).
Exosome Isolation
Supernatant was collected and centrifuged at 3003 g for 10min and 2,0003 g
for 10 min, followed by 100,000 3 g centrifugation in a Beckman Coulter Op-
tima MAX-XP with a TLA 100.3 rotor for 90 min (P100 fraction). EVs were then
subjected to further purification via sucrose density gradients consisting of
8%, 30%, 45%, and 60% layers in PBS and centrifuged at 232,000 3 g for
30 min to 18 hr at 4C. 10 fractions were collected, diluted 1:10 in PBS, and
centrifuged for 1 hr at 100,000 3 g. Each fraction was re-suspended in 43
Laemmli buffer and subjected to western blotting or PBS for further analysis.
For exosome transfection experiments, P100 fractions were resuspended in
2.5 M sucrose, and density gradients were constructed from 2.5 M to
0.25 M (2.5 M, 2M, 1.5 M, 1M, 0.5 M, and 0.25 M). Gradients were centrifuged
at 100,0003 g for 18 hr at 4C. 10 Fractions were collected and diluted 1:10 in
PBS and centrifuged for 1 hr at 100,000 3 g at 4C. Fractions were resus-
pended in Dulbecco’s PBS and stored at –20C.
Electron Microscopy
EVs suspended in 4% paraformaldehyde were embedded in a formvar car-
bon-coated grid, washed in PBS, fixed in 1% glutaraldehyde, and stained
with saturated aqueous uranyl oxalate. EVs were embedded in 0.4% w/v ura-
nyl acetate and 1.8% w/v methylcellulose. Samples were imaged with a Carl
Zeiss 910 electron microscope (Carl Zeiss Microscopy, Thornwood, NY).
Neonatal Transplantation and Click-iT EdU Labeling
DiI-labeled P100 fractions were preloaded into capillary tubes and loaded with
2 mL of EV/DiI/PBS mixture, and EVs were injected into the lateral ventricle.
Pups were placed onto a heating pad for 5 min until recovered and placed
back into cages. Medium collected from cultured microglia was loaded into
capillary tubes, and approximately 2 mL of medium was transplanted into the
lateral ventricles of P0 pups. The Click-iT EdU imaging kit (Invitrogen,
C10338) was used according to the manufacturer’s protocol to assess
proliferation.
DiI Labeling of P100 Fractions
P100 fractions were isolated as described above. P100 fractions were centri-
fuged at 14,000 3 g for 30 min. Pellets were re-suspended in PBS and sub-
jected to DiI labeling (1:1,000 at room temperature [RT], Life Technologies,
V22889) for 10 min while vortexing periodically during incubation. DiI-labeled
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P100 fractions were centrifuged at 14,0003 g for 30 min and re-suspended in
13PBS. Centrifugation was repeated a total of three times. The final pellet was
re-suspended in 50 mL 13 PBS and stored at –20C.
Western Blot
Samples were lysed in radioimmunoprecipitation assay (RIPA) buffer, 2%
SDS, and Halt protease and phosphatase inhibitor cocktail (Thermo Fisher
Scientific). Samples were placed on ice, sonicated with a Q55 sonicator
(QSonica), and centrifuged, and the supernatant was placed into fresh tubes.
The following antibodies were used: CD63 (1:1,000, System Biosciences),
CD9 (1:1,000, System Biosciences), ALIX (3A9, 1:1,000, Cell Signaling Tech-
nology, 21711), b-tubulin III (Aves Labs, TUJ), or His tag (D3I1O, 1:1,000,
Cell Signaling Technology, 12698). Horseradish peroxidase (HRP)-conjugated
antibodies from Life Technologies were used as a secondary antibody
(1:3,333–1:5,000). polyvinylidene fluoride (PVDF) membranes were incubated
with ECL substrate (Pierce) and exposed to Amersham Hyperfilm ECL (GE
Healthcare).
Primary Neural Stem Cell Culture and Immunocytochemistry
The protocol was derived from Walker and Kempermann (2014). Cells
were cultured in 500 mL Neurobasal A complete medium (13 Glutamax,
50 units/mL penicillin/streptomycin, 20 ng/mL epidermal growth factor
(EGF), 20 ng/mL fibroblast growth factor 2 (FGF-2), and 2% B27 Supplement).
Cells were placed on laminin-coated plates or coverslips in 24-well plates in
Neurobasal A complete medium. The following day, complete media was re-
freshed, and the supernatant was stored at –20C.
24 hr later, culture medium was collected and used for exosome and P100
isolation. Cells were lysedwith 13RIPA, 2%SDS, and PBS and used for west-
ern blotting or fixed by adding equal volumes of 37C fixative solution (4%
paraformaldehyde in 300 mM sucrose and Neurobasal A) directly to the wells
and incubated at 37C for 10 min. Coverslips were then washed three times,
blocked in antibody buffer (PBS, 2% BSA, and 0.1% Tween 20) with 0.1%
Triton X-100 and then washed again three times. Coverslips were incubated
with antibodies against anti-CD9 mouse (eBioscience, 1:1,000), Nestin
(Novus, 1:1,000), Iba1 (Vector Laboratories, VP-RM04, 1:500), and DCX (Santa
Cruz Biotechnology, C-18, 1:500), washed three times, and then incubated in
antibody buffer with the appropriate secondary antibodies (1:1,000, Life Tech-
nologies). Following four 15-min washes, coverslips were mounted in ProLong
Gold Antifade with DAPI (Life Technologies) on Superfrost microscope slides
(Thermo Scientific).
Analysis: Distribution
Co-localization and distribution of CD9-GFP in electroporated postnatal neural
stem cells were analyzed using Fiji. z stack images were loaded into Fiji soft-
ware, Z-projected (Max Intensity), and separated from stacks to images based
on fluorescent channels (i.e., green, red, or blue). Brightness/contrast was
adjusted for each Z-projected image to reduce background noise. Using the
Co-localization plugin in Fiji, Z-projected images were assessed for co-local-
ization of CD9-GFP and Tomato. The co-localization threshold of each image
was set between 85–130 using 5-point increments when adjusting. Images
were subjected to particle analysis through the Analyze Particle plugin. Green
particle size was set from 1 micron to infinity to detect small CD9-GFP parti-
cles, and Tomato particle size was set from 10 microns to infinity to only count
the number of cells and not cell debris. The percentage of CD9-GFP and To-
mato co-localization was recorded.
DiI and Cell Type Co-localization (Iba1, CD11b, and CD68)
Images were loaded into Fiji (ImageJ) and converted into composite images.
Z sections were selected based on DiI and Iba1/CD11b/CD68 co-localization
within the selected Z section. Selected sections were Z-projected using max
project and separated into individual color channels. Brightness and contrast
were adjusted to correct for background noise within each image. Co-localiza-
tion analysis was performed on Z-projected DiI and Iba1/CD11b/CD68 im-
ages. Co-localized images were converted to 8 bits, inverted, and thresholded
to 0 and 255 (only co-localized particles were visible). Thresholds of Z-pro-
jected DiI and Iba1/CD11b/CD68 images were set to 10/255 and 85–100/
255, respectively. All images were then subjected to particle analysis. The per-
centage of co-localized DiI particles was in relation to the total number of DiI
particles.
Morphological Analysis: Ellipticity and Process Number
Cellular ellipticity was measured using Shape Description in Particle Analysis
in ImageJ. Images were loaded into ImageJ, Z-projected, and separated
into individual channels (green, red, and blue). Thresholds were set at 100–
120 and 255. Cells either in the SVZ or in the ventricular wall were outlined us-
ing the freehand tool and assessed through particle analysis. Circularity was
reported as a value between 0 and 1, with 1 describing a perfect circle. Micro-
glia complexity analysis was conducted using Leica Application Suite X (LASx)
1.1.0.12420 3D module software. Processes of Iba1+ cells were quantified
manually in the 3D module. The average number of processes in DiI+/Iba1+
cells was compared with DiI-/Iba1+ cells.
Nanosight Particle Tracking Analysis
Samples were shipped on wet ice to the Nanomedicine Characterization Core
facility in the Center for Nanotechnology in Drug Delivery at the University of
North Carolina (UNC) at Chapel Hill. Samples were prepared in a laminar
flow hood and thawed at RT. Sample dilutions were based on an initial run
with PBS, 10 mM salt. Samples were loaded onto a pre-cleaned and pre-
warmed Nanosight NS 500 nanoparticle characterization system (NanoSight,
UK) equipped with a 532-nm laser and a 565-nm long pass filter. Mean size
and particle concentration values were calculated by the nanoparticle tracking
software. The Nanosight NS 500 was calibrated with 100 nm polystyrene
latex microsphere standards (Nanosight, UK), and readings were acquired at
23.3C.
RNA Sequencing
For EV small RNA sequencing, RNA was isolated by Trizol extraction from EVs
from P100 fractions of primary SVZ NSCs. Samples were quantified using the
Agilent Bioanalyzer small RNA assay. Libraries were prepared according to
manufacturer’s protocol (Illumina small RNA preparation kit). Samples were
subjected to 1 3 75 bp single-end reads at an approximate depth of 10–15
million reads per sample on an Illumina Hi-Seq.
RNA was isolated from microglia cell cultures using Trizol in accordance
with the manufacturer’s protocol. Three samples from 1–2 RNA isolations for
each condition were used to generate libraries. RNA concentrations and purity
were assessed by Nanodrop, Qubit assay, and Agilent Tapestation. RNA li-
brary preparation with poly(A) selection was performed using the NEBNext Ul-
tra RNA Library Preparation Kit according to the manufacturer’s protocol (New
England Biolabs). 23 150 bp reads were generated at a depth of 56–84 million
reads per sample on an Illumina HiSeq. Samples had a mean quality score of
38.52, with 92.76% of bases having a R Q30 score. Sequence reads were
trimmed to remove possible adaptor sequences and nucleotides with poor
quality using Trimmomatic v0.36. The reads were then mapped to the Mus
musculus GRCm38 reference genome available on ENSEMBL using the
STAR aligner. The RNA sequencing (RNA-seq) aligner is executed using a
splice aligner that detects splice junctions and incorporating them to help align
the entire read sequences. Unique exon hit counts were calculated using
feature counts from the Subread package. After mapping and unique exon
hit count calculations, downstream differential expression analysis was per-
formed using DESeq2. Gene ontology (GO) analysis was performed on the
statistically significant set of genes by implementing the software GeneSCF.
The Mouse Genome Informatics GO list was used to cluster the set of genes
based on their biological process and determine their statistical significance.
Gene interaction networks were determined by Cytoscape 3.60 using
Genemania.
Luminex
Cytokine concentrations were quantified with the cytokine multiplex assay
from Bio-Rad as described previously (Racicot et al., 2017). Wells of a 96-
well filter plate were loaded with 50 mL of prepared standard solution or
50 mL of cell-free supernatant and incubated with the Bio-Plex Pro mouse
23-plex assay from Bio-Rad at ± 800 rpm for 30 min in the dark at RT. Wells
were vacuum-washed three times with 100 mL wash buffer. Samples were
then incubated with 25 mL of biotinylated detection antibody at ± 800 rpm
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for 30 min at RT in the dark. After three washes, 50 mL of streptavidin-phyco-
erythrin was added to each well and incubated for 10 min at ± 800 rpm at RT in
the dark. After a final wash, the beads were resuspended in 125 mL of sheath
buffer for measurement with the Luminex 200 (Luminex, Austin, TX)
Microglia Culture
24 hr prior to platingmicroglia, 6 well plates were coatedwith 10 mg/mL poly-L-
lysine according to the supplier’s instructions. The protocol was derived from
Bohlen et al. (2017). Primary microglia cells isolated from CD1 mice were re-
constituted in a 37C water bath immediately prior to plating. For immunohis-
tochemistry following exosome treatment experiments, 3,500 cells were
plated in 500 mL microglia complete medium (2 ng/mL TGF-b2, 100 ng/mL
IL-34, 1.5 mg/mL cholesterol, 100 units/mL penicillin-streptomycin [pen-
strep], 13 Glutamax, and microglia medium [Sciencell, 1901]) and allowed
to adhere for 10 min at RT in 24-well plates.
Exo-fection
After sucrose density gradient isolation of Neuro-2a exosomes or extracel-
lular vesicles, the respective vesicles were transfected (System Biosciences,
EXFT10A-1). In brief, isolated vesicles were mixed with 10 mL Exo-Fect solu-
tion, synthetic Let-7 miRNAs (Sigma; HMI0007, HMI0009, and HMI0017,
which also correspond to mouse Let-7), and Dulbecco’s phosphate-buffered
saline (dPBS). Tubes were incubated at 37C for 10 min then immediately
placed on ice. Samples were centrifuged at 14,000 x g for 15 min at 4C.
Samples were either used to treated cultured primary microglia or labeled
with DiI and injected into the lateral ventricles of P0 pups as described
previously.
Statistics
Statistics were performed with Prism software (version 6; GraphPad). Signifi-
cancewas calculated using unpaired t tests and one-way ANOVAwith Tukey’s
multiple comparisons test. Statistical significance was defined as p < 0.05. All
data are presented as mean ± SEM. The Wald test, p values, and absolute
Log2Fold changes were generated for gene expression analysis. Genes with
adjusted p < 0.05 and absolute Log2Fold change > 2 were called as differen-
tially expressed genes for each comparison.
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